Early Experience Implementing Long-Acting Injectable Cabotegravir/Rilpivirine for Human Immunodeficiency Virus-1 Treatment at a Ryan White-Funded Clinic in the US South

BACKGROUND: Long-acting injectable (LAI) antiretroviral therapy (ART) has the potential to improve medication adherence, reduce human immunodeficiency virus (HIV) stigma, and promote equity in care outcomes among people with HIV (PWH). We describe our early experience implementing LAI-cabotegravir/r...

Descripción completa

Detalles Bibliográficos
Autores principales: Collins, Lauren F, Corbin-Johnson, Della, Asrat, Meron, Morton, Zoey P, Dance, Kaylin, Condra, Alton, Jenkins, Kimberly, Todd-Turner, Marie, Sumitani, Jeri, Smith, Bradley L, Armstrong, Wendy S, Colasanti, Jonathan A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487705/
https://www.ncbi.nlm.nih.gov/pubmed/36147599
http://dx.doi.org/10.1093/ofid/ofac455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487705/
https://www.ncbi.nlm.nih.gov/pubmed/36147599
http://dx.doi.org/10.1093/ofid/ofac455

Ejemplares similares